What is R65 Labs?
R65 Labs operates at the intersection of neuroscience and behavioral science, focusing on the development of scalable solutions for brain health and learning readiness. By leveraging its proprietary technology, the company seeks to address complex challenges in human performance. Its flagship program, BrainDay, serves as a foundational pillar for this mission, evolving from the earlier Prologue platform to provide a more robust framework for cognitive enhancement. The company is currently transitioning into a phase of rapid program expansion, aiming to deploy a suite of initiatives designed to foster measurable behavior change across diverse user demographics.
How much funding has R65 Labs raised?
R65 Labs has raised a total of $2.8M across 1 funding round:
Debt
$2.8M
Debt (2020): $2.8M, investors not publicly disclosed
Key Investors in R65 Labs
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for R65 Labs?
With the recent influx of capital, R65 Labs is poised to scale its operational capacity and broaden its research initiatives. The company's strategic roadmap indicates a shift toward enterprise-level deployment of its cognitive health tools, moving beyond initial pilot programs to achieve wider market penetration. By prioritizing the development of new programs that build upon the BrainDay architecture, R65 Labs intends to solidify its position as a leader in the human performance sector. Future growth will likely be driven by data-backed efficacy studies and the integration of its behavioral change methodologies into broader health and wellness ecosystems, ensuring long-term sustainability and impact.
See full R65 Labs company page
